A committee of experts convened by the British government is concerned by risk of antibiotic resistance which causes “10 million deaths a year” in the world by 2050, causing erosion of global GDP by 2% to 3.5%.

A continuous increase of antibiotic resistance from 2050 would cause the death of 10 million people per year and a reduction of 2% to 3.5% of gross domestic product (GDP)“, said the report drafted by a group of international experts set up by David Cameron in July 2014 and chaired by Mr. O’Neill, former chief economist of Goldman Sachs. Deaths occur mainly in Asia (4.7 million) and Africa (4.1 million). In Europe, the study predicts an annual average of 390.000 deaths. It would be 317.000 in the United States. This would become the first cause of mortality in the world before cancer that would kill 8.2 million people, diabetes (1.5 million deaths per year), diarrhea (1.4 million) or road accidents (1.2 million). “The study estimates at 300 million the number of people expected to die prematurely because of drug resistance during the next 35 years,” which is based on two prospective studies at the request of the Commission by ‘research institute Rand Europe and the auditing firm KPMG. “Financially, it costs much less to take account of drug resistance rather than doing nothing,” said the report which notably calls for the creation of new drugs. Because of antibiotic resistance today we totalize 700.000 deaths per year worldwide, including 50.000 in Europe and the United States, says this study. In announcing the creation of a working group, the British Prime Minister had described as “real and ominous threat” the rapid development of resistant bacteria worldwide, fearing that the ineffectiveness of antibiotics can return the world “in the Middle Ages of medicine, with deaths caused by infections and injuries that can be treated today“. World consumption of antibiotics in humans rose nearly 40% between 2000 and 2010, specified the report. Among the bacteria that already show a resistance to antibiotics, according to this study, include Klebsiella pneumonia (respiratory tract infection), E. coli (intestinal bacteria) and Staphylococcus aureus. Zoonotic AMR reports from the EC underline the necessity to act  as it leads to problems in respect of public health.

  • Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations, Jim O’Neill, 2014; p. 4.
  • Antimicrobial Resistance in the Animal Health Strategy, European Commission, Dr. de Smet, 2009; p. 1-14.

Probiotic Group’s answer

Expectations with regard to hygiene are very demanding in many settings such as, for example, hospitals, laboratories, medical and dental practices, nursing houses and schools. In recent years, the objectives of high standards for clean and aseptic environments became more and more difficult to meet. Moreover, the persons responsible face every day insoluble problems of nosocomial infections especially in hospitals. Chemical cleaning agents and disinfectants have been used for many decades. Nowadays their limits, harms and disadvantages become clear and the patients are the victims. The bottom line is that those chemical products induce the damage they are intended to prevent: infections.

Hospitals evolve gradually from safe healing islands towards institutions people should better avoid or where they should stay as short as possible. Figures about nosocomial infections do not lie: there is talk of 700.000 infections per year in Italy for example; in the US at least 103.000 people die each year from nosocomial infections. Moreover patients need to stay for a longer time in a hospital because of those infections, costing millions of euros. Fact is in the US, nosocomial infections are one of the four main killers and more people die from nosocomial infection than from AIDS, breast cancer and car accidents combined.

The claim and policy statement of the Probiotic Project of Probiotic Group is: the current situation must change and it can be changed.

There is a need for introducing not only eco-friendly, more biological cleaning agents and techniques but also providing evidence of successful operating, in safety, effectiveness and quality of probiotic methods. Probiotic Group claims having developed a product formula able to restore safety to settings requiring high hygiene standards such as hospitals.  The scientific formula is capable for reducing pathogens significantly by 80% i.e. MRSA (Staphylococcus Aureus), E. coli, Pseudomonas aeruginosa, Candida albicans, Acinetobacter, Clostridium difficile. The same problems arise in animal husbandry and with growing frequency: as a result of the danger of resistance even more aggressive antiseptics, disinfectants and antibiotics are being used and posing new consumption risks to humans. Restoring the balance of the microbial community system on human and animal skin by probiotic techniques reduces significantly the risk of pathogenic contamination.

Possible applications can be developed in areas such as (1) medical, dental, veterinary (2) personal care (3) home care (4) pets (5) animal husbandry (6) air treatment. Also (7) vegetables and fruit could be treated with probiotics during the growth and flowering phases and thus the use of pesticides can be considerably reduced before it will be prohibited in June 2019.

In contrast to the above mentioned applications, probiotics – although in a different composition – have been used for decennia in water treatment.

Probiotic Group informs that the products under their project are not disinfectants and have no biocide-like action. Their products remove microscopical dirt and offensive odors, eliminate the biofilm and thereby create a bio-stabilization resulting in a significant reduction of unknown bacteria growth e.g. pathogenic bacteria.